Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (451-460 of 768) with videos related to

Pageof 77
Sort By:
Medicine|July 10, 2010
Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysisAmar Safdar, Jonathan Ma, Fouzi Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fractionMuzaffar H Qazilbash, Ali Imran Amjad, Suhail Qureshi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2010
Unrelated donor transplantation for acute myelogenous leukemia in first remissionQaiser Bashir, Borje S Andersson, Marcelo Fernandez-Vina, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2011
Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenibManish Sharma, Farhad Ravandi, Ulas Darda Bayraktar, et al.
British Journal of Haematology|March 8, 2016
Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantationRohtesh S Mehta, Rima M Saliba, Julianne Chen, et al.
Bone Marrow Transplantation|October 3, 2020
Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipientsAjay Sheshadri, Rima Saliba, Badar Patel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2010
Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem cell transplantationCarlos A Ramos, Rima M Saliba, Leandro de Pádua Silva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of ageC Hosing, R M Saliba, G-J Okoroji, et al.
Cytotherapy|May 16, 2006
AML-loaded DC generate Th1-type cellular immune responses in vitroD Xing, W K Decker, S Li, et al.
Blood|October 5, 2011
Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantationStefan O Ciurea, Peter F Thall, Xuemei Wang, et al.
Pageof 77

Showing results (451-460 of 768) with videos related to

Sort By:
Pageof 77
Medicine|July 10, 2010
Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysisAmar Safdar, Jonathan Ma, Fouzi Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fractionMuzaffar H Qazilbash, Ali Imran Amjad, Suhail Qureshi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2010
Unrelated donor transplantation for acute myelogenous leukemia in first remissionQaiser Bashir, Borje S Andersson, Marcelo Fernandez-Vina, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2011
Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenibManish Sharma, Farhad Ravandi, Ulas Darda Bayraktar, et al.
British Journal of Haematology|March 8, 2016
Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantationRohtesh S Mehta, Rima M Saliba, Julianne Chen, et al.
Bone Marrow Transplantation|October 3, 2020
Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipientsAjay Sheshadri, Rima Saliba, Badar Patel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2010
Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem cell transplantationCarlos A Ramos, Rima M Saliba, Leandro de Pádua Silva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of ageC Hosing, R M Saliba, G-J Okoroji, et al.
Cytotherapy|May 16, 2006
AML-loaded DC generate Th1-type cellular immune responses in vitroD Xing, W K Decker, S Li, et al.
Blood|October 5, 2011
Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantationStefan O Ciurea, Peter F Thall, Xuemei Wang, et al.
Pageof 77